| Literature DB >> 34337346 |
Yoshie Sakamaki1, John Ozdemir1, Zachary Heidrick1, Anthony Azzun1, Olivia Watson1, Miu Tsuji1, Christopher Salmon1, Arvind Sinha2, Joseph Batta-Mpouma2, Zachary McConnell1, David Fugitt1, Yuchun Du3, Jin-Woo Kim2, Hudson Beyzavi1.
Abstract
The field of photodynamic therapy (PDT) has continued to show promise as a potential method for treating tumors. In this work a photosensitizer (PS) has been delivered to cancer cell lines for PDT by incorporation into the metal-organic framework (MOF) as an organic linker. By functionalizing the surface of MOF nanoparticles with maltotriose the PS can efficiently target cancer cells with preferential uptake into pancreatic and breast cancer cell lines. Effective targeting overcomes some current problems with PDT including long-term photosensitivity and tumor specificity. Developing a PS with optimal absorption and stability is one of the foremost challenges in PDT and the synthesis of a chlorin which is activated by long-wavelength light and is resistant to photo-bleaching is described. This chlorin-based MOF shows anti-cancer ability several times higher than that of porphyrin-based MOFs with little toxicity to normal cell lines and no dark toxicity.Entities:
Keywords: drug delivery system (DDS); metal–organic framework (MOF); pancreatic cancer; photodynamic therapy (PDT); triple negative breast cancer (TNBC)
Mesh:
Substances:
Year: 2021 PMID: 34337346 PMCID: PMC8320713 DOI: 10.1021/acsabm.0c01324
Source DB: PubMed Journal: ACS Appl Bio Mater ISSN: 2576-6422